ARTICLE | Financial News

Aclaris, Kura price follow-ons

August 11, 2017 8:44 PM UTC

Dermatology play Aclaris Therapeutics Inc. (NASDAQ:ACRS) and cancer company Kura Oncology Inc. (NASDAQ:KURA) both priced follow-ons late Thursday, raising over $125 million total.

Aclaris raised $75 million though the sale of 3.3 million shares at $23.02. The offering was underwritten by Jefferies, Leerink, William Blair, Guggenheim and JMP Securities. The price is a 15% discount to Aclaris' close of $26.97 on Aug. 9, before it proposed the offering after market hours. Aclaris gained $2.06 to $25.08 on Friday...